Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,937.50 +941.09 (+1.40%) CMC Crypto 200
1,374.20 +43.59 (+3.28%)
Alector, Inc. (ALEC)
After hours:
| Previous close | 6.49 |
| Open | 6.57 |
| Bid | 6.46 x 200 |
| Ask | 6.49 x 100 |
| Day's range | 6.34 - 6.63 |
| 52-week range | 3.66 - 9.06 |
| Volume | |
| Avg. volume | 659,295 |
| Market cap | 625.536M |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.39 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.75 |
GlobeNewswireAlector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations related to the Company’s TREM2 and progranulin programs at the upcoming Alzheimer's Association International Conference® 2024 (AAIC®) being held online and in Philadelphia, Pennsylvania from July 28 – August 1, 2024.Poster presentations will be available for on-demand viewing beginning on July 28 at 8:00 a.
Insider MonkeyWhy Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Alector, Inc. (NASDAQ:ALEC) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities In 2024, the healthcare industry has been […]
ZacksProthena (PRTA) Moves 9.3% Higher: Will This Strength Last?
Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
